These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 34538955

  • 1. Follow-up and management of serologically active clinically quiescent cases in pediatric systemic lupus erythematosus.
    Capone G, Lojacono C, Al-Bayitee F, Makvandi S, Hennon T, Wrotniak B, Abdul-Aziz R.
    Reumatologia; 2021; 59(4):244-251. PubMed ID: 34538955
    [Abstract] [Full Text] [Related]

  • 2. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus.
    Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J.
    J Rheumatol; 2015 May; 42(5):810-6. PubMed ID: 25729033
    [Abstract] [Full Text] [Related]

  • 3. Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.
    Huang H, Mu L, Zhang Z, Gao D, Hao Y, Zhou W.
    Arthritis Res Ther; 2021 Oct 29; 23(1):275. PubMed ID: 34715915
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares.
    Walz LeBlanc BA, Gladman DD, Urowitz MB.
    J Rheumatol; 1994 Dec 29; 21(12):2239-41. PubMed ID: 7699623
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.
    Steiman AJ, Gladman DD, Ibañez D, Urowitz MB.
    Arthritis Care Res (Hoboken); 2012 Apr 29; 64(4):511-8. PubMed ID: 22162433
    [Abstract] [Full Text] [Related]

  • 10. Clinically active serologically quiescent systemic lupus erythematosus.
    Gladman DD, Hirani N, Ibañez D, Urowitz MB.
    J Rheumatol; 2003 Sep 29; 30(9):1960-2. PubMed ID: 12966598
    [Abstract] [Full Text] [Related]

  • 11. No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study.
    Ayano M, Hirata A, Tokunaga S, Furuhashi H, Kimoto Y, Ono N, Arinobu Y, Nakashima N, Akashi K, Horiuchi T, Niiro H.
    Rheumatol Int; 2024 Nov 29; 44(11):2411-2419. PubMed ID: 38668884
    [Abstract] [Full Text] [Related]

  • 12. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
    Miyawaki Y, Sada K, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Ohashi K, Morishita M, Watanabe H, Matsumoto Y, Kawabata T, Wada J.
    Lupus; 2018 Nov 29; 27(13):2093-2100. PubMed ID: 30309286
    [Abstract] [Full Text] [Related]

  • 13. Impaired phagocytosis of apoptotic cell material in serologically active clinically quiescent patients with systemic lupus erythematosis.
    Huang WN, Tso TK, Wu HC, Yang HF, Tsay GJ.
    Int J Rheum Dis; 2016 Dec 29; 19(12):1310-1316. PubMed ID: 26692544
    [Abstract] [Full Text] [Related]

  • 14. Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
    Fasano S, Coscia MA, Pierro L, Ciccia F.
    Lupus; 2021 May 29; 30(6):991-997. PubMed ID: 33709836
    [Abstract] [Full Text] [Related]

  • 15. Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.
    Steiman AJ, Gladman DD, Ibañez D, Urowitz MB.
    J Rheumatol; 2010 Sep 29; 37(9):1822-7. PubMed ID: 20595281
    [Abstract] [Full Text] [Related]

  • 16. Correlation between Systemic Lupus Erythematosus Disease Activity Index, C3, C4 and Anti-dsDNA Antibodies.
    Narayanan K, Marwaha V, Shanmuganandan K, Shankar S.
    Med J Armed Forces India; 2010 Apr 29; 66(2):102-7. PubMed ID: 27365721
    [Abstract] [Full Text] [Related]

  • 17. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
    Tseng CE, Buyon JP, Kim M, Belmont HM, Mackay M, Diamond B, Marder G, Rosenthal P, Haines K, Ilie V, Abramson SB.
    Arthritis Rheum; 2006 Nov 29; 54(11):3623-32. PubMed ID: 17075807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.
    Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M, Ghirardello A, Iaccarino L, Punzi L, Doria A.
    Clin Exp Rheumatol; 2012 Nov 29; 30(6):856-63. PubMed ID: 22765883
    [Abstract] [Full Text] [Related]

  • 20. Differentiating flare and infection in febrile lupus patients: Derivation and validation of a calculator for resource constrained settings.
    Mehta P, Singh K, Anand S, Parikh A, Patnaik A, Chatterjee R, Lawrence A, Tripathy SR, Kavadichanda C, Rajasekhar L, Vs N, Das B, Amita A.
    Lupus; 2022 Sep 29; 31(10):1254-1262. PubMed ID: 35786213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.